After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
TRVI belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Trevi Therapeutics Inc is $689.26M. A total of 0.72 million shares were traded on the day, compared to an average of 2.34M shares.
In the most recent transaction, SCIASCIA THOMAS sold 2,631 shares of TRVI for 6.60 per share on Mar 25 ’25. After the transaction, the Chief Scientific Officer now owns 221,373 company shares. In a previous transaction on Mar 21 ’25, GOOD JENNIFER L sold 5,263 shares at 6.58 per share. TRVI shares that President & CEO owns now total 213,313.
Among the insiders who bought shares, GOOD JENNIFER L acquired of 5,263 shares on Mar 21 ’25 at a per-share price of $6.58. In another insider transaction, Simon Farrell sold 81,313 shares at $6.75 per share on Mar 10 ’25. Company shares held by the Chief Commercial Officer now total 76,900.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, TRVI has a high of $7.39 and a low of $2.30.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. TRVI’s latest balance sheet shows that the firm has $36.83M in Cash & Short Term Investments as of fiscal 2021. There were $14.63M in debt and $12.72M in liabilities at the time. Its Book Value Per Share was $1.06, while its Total Shareholder’s Equity was $17.07M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TRVI is Buy with a score of 4.88.
